Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$624K Buy
+5,505
New +$546K 0.01% 871
2026
Q1
Sell
-2,246
Closed -$222K 1277
2025
Q4
$222K Buy
+2,246
New +$217K ﹤0.01% 1102
2024
Q1
Sell
-8,205
Closed -$515K 1109
2023
Q4
$515K Buy
8,205
+139
+2% +$7.86K 0.02% 724
2023
Q3
$466K Buy
8,066
+2,174
+37% +$137K 0.02% 706
2023
Q2
$367K Buy
5,892
+1,421
+32% +$95K 0.01% 739
2023
Q1
$323K Sell
4,471
-497
-10% -$38.9K 0.01% 771
2022
Q4
$399K Buy
+4,968
New +$380K 0.02% 640
2022
Q2
Sell
-2,532
Closed -$201K 769
2022
Q1
$201K Buy
+2,532
New +$184K 0.01% 704
2021
Q1
Sell
-3,827
Closed -$333K 494
2020
Q4
$333K Buy
+3,827
New +$331K 0.09% 286

Other funds holding INCY

Ethic Inc's INCY Position: Q2 2026 in Review

Ethic Inc opened a new position in Incyte (INCY) in Q2 2026: 5,505 shares worth $624K. The stake represents 0.01% of the portfolio and ranks #871 among its holdings. This is a return to the name: Ethic Inc previously reported a position in INCY as recently as Q4 2025.

Ethic Inc first reported a position in INCY in Q4 2020 and has held it in 9 quarters since. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Ethic Inc held 5,505 shares of Incyte worth $624K as of Q2 2026.
  • Incyte was a new Ethic Inc position in Q2 2026.
  • Incyte made up 0.01% of Ethic Inc's portfolio in Q2 2026, its #871 holding.
  • Ethic Inc first reported a position in Incyte in Q4 2020 and has held it in 9 quarters since.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.